Clinical manifestations and associated factors of uveitis in patients with pulmonary sarcoidosis: a case control study.
Chang-Min ChoiYe Eun HanJiyoul YangHo Cheol KimJunyeop LeePublished in: Scientific reports (2023)
Sarcoidosis, an idiopathic and inflammatory disease, affects various organs and can manifest as uveitis. Due to limited evidence, researchers investigated the risk factors associated with uveitis in patients with pulmonary sarcoidosis. A retrospective study was conducted on 71 pulmonary sarcoidosis patients, including 19 with uveitis and 52 without. Data on involved organs, imaging findings, spirometry, and analyses from blood and bronchoalveolar lavage fluid were collected. Logistic regression models were used for multivariate analysis. Among the 71 newly diagnosed pulmonary sarcoidosis patients, uveitis was observed in 19 patients (26.8%). No significant differences were found in clinical characteristics between patients with and without uveitis. Fewer patients with uveitis presented lung parenchymal lesions (P = 0.043). In multivariate analysis, skin lesions (aOR 7.619, 95% CI 1.277-45.472, P = 0.026) and ophthalmic symptoms (aOR 4.065, 95% CI 1.192-13.863, P = 0.025) were associated with uveitis. Absence of uveitis was related to lung parenchymal lesions (aOR 0.233, 95% CI 0.062-0.883, P = 0.032). Approximately one-quarter of patients with an initial diagnosis of pulmonary sarcoidosis were diagnosed with uveitis. Presence of skin lesions, ophthalmic symptoms, and absence of lung parenchymal lesions were related to uveitis. These results need to be clarified by further studies to confirm the clinical role of early ophthalmologic screening for pulmonary sarcoidosis patients with these factors.
Keyphrases
- juvenile idiopathic arthritis
- ankylosing spondylitis
- newly diagnosed
- end stage renal disease
- pulmonary hypertension
- ejection fraction
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- oxidative stress
- disease activity
- machine learning
- systemic lupus erythematosus
- patient reported outcomes
- big data
- deep learning
- lung function
- soft tissue
- drug induced